107 related articles for article (PubMed ID: 9792303)
1. B-cell chronic lymphocytic leukaemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigen.
Mulligan SP; Dao LP; Francis SE; Thomas ME; Gibson J; Cole-Sinclair MF; Wolf M
Br J Haematol; 1998 Oct; 103(1):157-62. PubMed ID: 9792303
[TBL] [Abstract][Full Text] [Related]
2. CD8 expression in B chronic lymphocytic leukemia: A case of immuno-phenotypic aberrancy.
Jain M; Kushwaha R; Verma SP; Singh US; Tripathi AK; Goel MM; Kumar A
Cytometry B Clin Cytom; 2018 Jul; 94(4):679-682. PubMed ID: 28557280
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of the CD8 antigen in B cell chronic lymphocytic leukaemia.
Espinosa A; Bjørk P; Magnussen K; Moen T; Sørum Y
Leuk Lymphoma; 2003 Jan; 44(1):193-6. PubMed ID: 12691163
[TBL] [Abstract][Full Text] [Related]
4. CD8-positive B-cell chronic lymphocytic leukemia. A report of two cases.
Koelliker DD; Steele PE; Hurtubise PE; Flessa HC; Sheng YP; Swerdlow SH
Am J Clin Pathol; 1994 Aug; 102(2):212-6. PubMed ID: 8042591
[TBL] [Abstract][Full Text] [Related]
5. Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome.
Till KJ; Allen JC; Talab F; Lin K; Allsup D; Cawkwell L; Bentley A; Ringshausen I; Duckworth AD; Pettitt AR; Kalakonda N; Slupsky JR
Sci Rep; 2017 Dec; 7(1):16784. PubMed ID: 29196709
[TBL] [Abstract][Full Text] [Related]
6. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells.
Talab F; Allen JC; Thompson V; Lin K; Slupsky JR
Mol Cancer Res; 2013 May; 11(5):541-54. PubMed ID: 23505068
[TBL] [Abstract][Full Text] [Related]
7. Regulation of T cell receptor expression in immature CD4+CD8+ thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules.
Wiest DL; Yuan L; Jefferson J; Benveniste P; Tsokos M; Klausner RD; Glimcher LH; Samelson LE; Singer A
J Exp Med; 1993 Nov; 178(5):1701-12. PubMed ID: 8228817
[TBL] [Abstract][Full Text] [Related]
8. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.
Ramsay AG; Johnson AJ; Lee AM; Gorgün G; Le Dieu R; Blum W; Byrd JC; Gribben JG
J Clin Invest; 2008 Jul; 118(7):2427-37. PubMed ID: 18551193
[TBL] [Abstract][Full Text] [Related]
9. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S; Goddard RV; Kaminski ER; Prentice AG
Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
[TBL] [Abstract][Full Text] [Related]
10. Aberrant CD8 antigen expression in a patient with B chronic lymphocytic leukaemia showing unusual disease progression.
Ghosh K; Sivakumaran M; Wood JK
Br J Haematol; 1993 Sep; 85(1):205-6. PubMed ID: 8251395
[TBL] [Abstract][Full Text] [Related]
11. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
12. Expression of the T-cell-specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells.
Majolini MB; D'Elios MM; Galieni P; Boncristiano M; Lauria F; Del Prete G; Telford JL; Baldari CT
Blood; 1998 May; 91(9):3390-6. PubMed ID: 9558397
[TBL] [Abstract][Full Text] [Related]
13. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
14. [A case of chronic B cell lymphocytic leukemia with expression of CD8 antigen on leukemic cells].
Roliński J; Rupniewska ZM; Wasik-Szczepanek EA
Pol Arch Med Wewn; 1998 Jan; 99(1):48-55. PubMed ID: 9686504
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood lymphocyte phenotype of ZAP-70⁺ and ZAP-70⁻ patients with B-cell chronic lymphocytic leukaemia.
Rivkina A; Holodnuka-Kholodyuk I; Murovska M; Soloveichika M; Lejniece S
Exp Oncol; 2015 Mar; 37(1):73-6. PubMed ID: 25804237
[TBL] [Abstract][Full Text] [Related]
16. CD8+ chronic lymphocytic leukemia: an extensive characterization of a bizarre hybrid neoplasia.
Richaud-Patin Y; Piedras J; Carrillo-Maravilla E; López-Karpovitch X; Llorente L
Eur J Haematol; 2003 Sep; 71(3):224-30. PubMed ID: 12930326
[TBL] [Abstract][Full Text] [Related]
17. Assembly of the CD8alpha/p56(lck) protein complex in stably expressing rat epithelial cells.
Pascale MC; Remondelli P; Leone A; Bonatti S
FEBS Lett; 2000 Sep; 480(2-3):226-30. PubMed ID: 11034334
[TBL] [Abstract][Full Text] [Related]
18. Aberrant phenotypic expression of the T-cell-associated antigen CD8 on B-cell chronic lymphocytic leukemia cells.
Stagno F; Triolo A; Del Fabro V; Berretta S; Parrinello NL; Fargione G; Di Raimondo F
Lab Hematol; 2009; 15(1):1-3. PubMed ID: 19273392
[TBL] [Abstract][Full Text] [Related]
19. Lineage-specific control of superantigen-induced cell death by the protein tyrosine kinase p56(lck).
Penninger JM; Wallace VA; Molina T; Mak TW
J Immunol; 1996 Dec; 157(12):5359-66. PubMed ID: 8955183
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.
Contini P; Ghio M; Merlo A; Poggi A; Indiveri F; Puppo F
J Immunol; 2005 Dec; 175(11):7244-54. PubMed ID: 16301629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
